Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
American Journal of Clinical Oncology|June 1, 2005
Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreasAdrian A Wong, Mark E Delclos, Robert A Wolff, et al.Investigational New Drugs|August 5, 2004
A phase I surrogate endpoint study of SU6668 in patients with solid tumorsHenry Q Xiong, Roy Herbst, Silvana C Faria, et al.Annals of Surgical Oncology|July 26, 2006
Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapyGauri R Varadhachary, Eric P Tamm, James L Abbruzzese, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668Darren W Davis, Ryan Takamori, Chandrajit P Raut, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastasesJean-Nicolas Vauthey, Timothy M Pawlik, Dario Ribero, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinomaMark J Ratain, Tim Eisen, Walter M Stadler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancerChristopher H Crane, Lee M Ellis, James L Abbruzzese, et al.The Oncologist|September 23, 2017
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER TrialAndrew H Ko, Patrick B Murphy, James D Peyton, et al.Pageof 3